Rhythm Pharmaceuticals Inc (RYTM)
37.99
-1.18
(-3.01%)
USD |
NASDAQ |
May 17, 16:00
37.99
0.00 (0.00%)
After-Hours: 20:00
Rhythm Pharmaceuticals Free Cash Flow: -140.47M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -140.47M |
| December 31, 2023 | -136.20M |
| September 30, 2023 | -140.82M |
| June 30, 2023 | -158.65M |
| March 31, 2023 | -160.43M |
| December 31, 2022 | -177.71M |
| September 30, 2022 | -184.25M |
| June 30, 2022 | -177.43M |
| March 31, 2022 | -171.65M |
| December 31, 2021 | -151.44M |
| September 30, 2021 | -140.10M |
| June 30, 2021 | -127.00M |
| March 31, 2021 | -119.64M |
| Date | Value |
|---|---|
| December 31, 2020 | -122.19M |
| September 30, 2020 | -125.21M |
| June 30, 2020 | -131.91M |
| March 31, 2020 | -130.04M |
| December 31, 2019 | -126.14M |
| September 30, 2019 | -115.29M |
| June 30, 2019 | -98.69M |
| March 31, 2019 | -83.32M |
| December 31, 2018 | -62.78M |
| September 30, 2018 | -49.34M |
| June 30, 2018 | -40.58M |
| March 31, 2018 | -34.10M |
| December 31, 2017 | -29.46M |
Free Cash Flow Range, Past 5 Years
-184.25M
Minimum
Sep 2022
-98.69M
Maximum
Jun 2019
-141.76M
Average
-138.15M
Median
Free Cash Flow Benchmarks
| Pfizer Inc | 5.106B |
| Amicus Therapeutics Inc | -88.03M |
| Insmed Inc | -588.55M |
| Altimmune Inc | -72.76M |
| Regeneron Pharmaceuticals Inc | 3.930B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -40.74M |
| Cash from Investing (Quarterly) | 30.05M |
| Cash from Financing (Quarterly) | 4.243M |
| Free Cash Flow Per Share (Quarterly) | -0.6774 |
| Free Cash Flow to Equity (Quarterly) | -40.74M |
| Free Cash Flow to Firm (Quarterly) | -39.03M |
| Free Cash Flow Yield | -6.32% |